Search

Your search keyword '"BELLONE S."' showing total 792 results

Search Constraints

Start Over You searched for: Author "BELLONE S." Remove constraint Author: "BELLONE S."
792 results on '"BELLONE S."'

Search Results

103. Use of PPM (Plant Preservative Mixture) to control bacterial contaminants in the multiplication in vitro of sugarcane

109. Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivo

113. The nutritional status has no major role in the age-related reduction of IGF-I secretion

119. Growth hormone deficiency in the transition adolescent: should treatment be continued in adult life?

120. Thyroid metastases from renal clear cell carcinoma: a cyto-histological study of two cases

125. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

130. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults

131. Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy

134. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy.

135. Measurement of height velocity is an useful marker for monitoring pituitary function in patients who had traumatic brain injury

137. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy

138. Mammaglobin B (SCGB2A1)-specific CD8+ cytotoxic T lymphocytes (CTL) are highly effective in killing autologous chemotherapy resistant ovarian cancer cells: Implications for SCGB2A1 dendritic cell-based therapeutic vaccines

141. Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer

142. Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling.

143. The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.

144. A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

145. Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab

147. The effect of intraperitoneal administration of clostridium perfringens enterotoxin on chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice.

149. Analytical model of GaAs BMFET structures

Catalog

Books, media, physical & digital resources